Undisclosed NMUR2–GIPR dual agonist
/ Boehringer Ingelheim
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 22, 2026
A Long-Acting NMUR2–GIPR Dual Agonist Provides Additive Body‑Weight Loss by Modulation of Complementary Satiety Pathways
(OBESITY WEEK 2026)
- No abstract available
Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1